Valuation : GI Innovation, Inc.

Market Cap 52TCr 38Cr 33Cr 31Cr 28Cr 53Cr 3.62TCr 53Cr 363Cr 141.63Cr 1.83TCr 142.18Cr 139.09Cr 6.06TCr P/E 2024
-6.04x
P/E 2025 -29.2x
Enterprise Value 49TCr 35Cr 30Cr 29Cr 26Cr 49Cr 3.38TCr 49Cr 338.92Cr 132.23Cr 1.71TCr 132.75Cr 129.86Cr 5.66TCr EV / Sales 2024
15,970x
EV / Sales 2025 187x
Free-Float
93.28%
Yield 2024 *
-
Yield 2025 -
1 day+0.87%
1 week+6.03%
Current month+9.18%
1 month+6.17%
3 months-49.12%
6 months-49.88%
Current year-54.14%
1 week 7,560
Extreme 7560
8,530
1 month 6,470
Extreme 6470
9,650
Current year 6,470
Extreme 6470
18,830
1 year 6,470
Extreme 6470
21,000
3 years 6,470
Extreme 6470
24,900
5 years 6,470
Extreme 6470
24,900
10 years 6,470
Extreme 6470
24,900
Manager TitleAgeSince
Chief Executive Officer 58 02/07/2025
Chief Executive Officer 54 16/06/2021
Director of Finance/CFO - 01/09/2024
Director TitleAgeSince
Director/Board Member 54 16/06/2021
Director/Board Member 58 01/07/2017
Director/Board Member 64 01/03/2022
Date Insider Type Main position Quantity % Market Cap.
20/01/26 Expiration 14 0.0000%
20/01/26 Fiscal year

Chief Technology Officer

445 0.0007%
20/01/26 Fiscal year 14 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.87%+6.03%-51.96%-25.06% 38Cr
-0.78%-1.42%+2.49%+22.78% 5.05TCr
-6.00%-0.75%+442.41%+544.39% 4.46TCr
-0.24%+0.74%+38.69%+18.02% 4.31TCr
-1.55%-2.07%+23.08%+81.47% 4.17TCr
-0.31%-0.83%+16.15%+51.42% 3.32TCr
-1.79%-3.24%+27.00%+129.56% 1.68TCr
-0.58%-2.12% - - 1.63TCr
-0.88%-0.66%+11.60%+27.75% 1.46TCr
-1.66%-1.25%+78.59%+46.66% 1.39TCr
Average -1.29%-1.04%+65.34%+99.67% 2.75TCr
Weighted average by Cap. -1.70%-1.06%+95.49%+133.40%

Financials

2024 2025
Net sales 2.43Cr 17.62T 15.18T 14.23T 12.99T 24.48T 16.84L 24.56T 2L 65.89T 8L 66.15T 64.71T 28.18L 583.81Cr 42.36L 36.5L 34.22L 31.24L 58.85L 40Cr 59.04L 4.06Cr 1.58Cr 20Cr 1.59Cr 1.56Cr 68Cr
Net income -5.88TCr -4.27Cr -3.68Cr -3.45Cr -3.15Cr -5.93Cr -407.64Cr -5.94Cr -41Cr -16Cr -205.78Cr -16Cr -16Cr -682.32Cr -3.51TCr -2.55Cr -2.2Cr -2.06Cr -1.88Cr -3.54Cr -243.64Cr -3.55Cr -24Cr -9.53Cr -122.99Cr -9.57Cr -9.36Cr -407.81Cr
Net Debt -343.96Cr -24.96L -21.51L -20.16L -18.41L -34.67L -24Cr -34.78L -2.39Cr -93.34L -12Cr -93.7L -91.66L -40Cr -3.46TCr -2.51Cr -2.16Cr -2.03Cr -1.85Cr -3.49Cr -240.12Cr -3.5Cr -24Cr -9.4Cr -121.21Cr -9.43Cr -9.23Cr -401.92Cr
Logo GI Innovation, Inc.
GI Innovation Inc is a Korea-based company engaged in the research and development of next-generation immunotherapies based on fusion proteins. The Company is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.
Employees
-
Date Price Change Volume
28/26/28 ₩8,090.00 +0.87% 2,21,953
27/26/27 ₩8,020.00 -3.84% 2,99,397
26/26/26 ₩8,340.00 +4.25% 4,90,279
25/26/25 ₩8,000.00 -1.96% 2,05,152
24/26/24 ₩8,160.00 +6.95% 3,41,406
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
  1. Stock Market
  2. Stocks
  3. A358570 Stock